OWENS DAVID (Chief Medical Officer) purchased 0.7% of their position (1K shares) of NEXALIN TECHNOLOGY, INC. on the open market
Open‑market purchase worth $1.8K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/1/2024ACC: 0001829126-24-004517
DirectorOfficer· Chief Medical Officer
Since Sep 2022
+1K
Net shares
Net buyer
$1.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1K acquired
Non-Derivative Transactions1
Common stock
Direct
Shares
+1K
Price / share
$1.75
Trade value
$1.75K
% of position
0.7%
6/28/2024
145.79K→146.79K
Total
Net shares
+1K
Net value
$1.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 6/28/2024 | P · Purchase | +1K | $1.75 | $1.75K | 0.7% | 145.79K | 146.79K |
| Total | +1K | $1.75K | ||||||
Derivative Transactions0
No derivative transactions reported